Abstract
Five enantioselective sensors based on α-, β-, carboxymethyl-β-(as sodium salt), 2-hydroxyl-3-trimethylammoniopropyl -β-(as chloride salt) and γ-cyclodextrins were designed based on results of their molecular interaction with the S- and R-enantiomers of ketoprofen obtained using SPR (surface plasmon resonance) based sensors. SPR proved to be an excellent technique for selecting the best chiral selectors. The best sensor was the one based on β-cyclodextrin. Low detection limits (of 10-8 to 10-9 magnitude orders) were recorded with the enantioselective, potentiometric membrane electrodes.
Keywords: Cyclodextrin, enantioanalysis, enantioselective, potentiometric membrane electrode, S-ketoprofen, surface plasmon resonance.
Current Drug Therapy
Title:Design of Potentiometric Sensors Based on Interaction of Cyclodextrins with the Enantiomer of Interest
Volume: 9 Issue: 4
Author(s): Raluca-Ioana Stefan-van Staden, Rahel Girmai Bokretsion, Jacobus Frederick van Staden and Hassan Y Aboul-Enein
Affiliation:
Keywords: Cyclodextrin, enantioanalysis, enantioselective, potentiometric membrane electrode, S-ketoprofen, surface plasmon resonance.
Abstract: Five enantioselective sensors based on α-, β-, carboxymethyl-β-(as sodium salt), 2-hydroxyl-3-trimethylammoniopropyl -β-(as chloride salt) and γ-cyclodextrins were designed based on results of their molecular interaction with the S- and R-enantiomers of ketoprofen obtained using SPR (surface plasmon resonance) based sensors. SPR proved to be an excellent technique for selecting the best chiral selectors. The best sensor was the one based on β-cyclodextrin. Low detection limits (of 10-8 to 10-9 magnitude orders) were recorded with the enantioselective, potentiometric membrane electrodes.
Export Options
About this article
Cite this article as:
Staden Stefan-van Raluca-Ioana, Bokretsion Girmai Rahel, van Staden Frederick Jacobus and Aboul-Enein Y Hassan, Design of Potentiometric Sensors Based on Interaction of Cyclodextrins with the Enantiomer of Interest, Current Drug Therapy 2014; 9 (4) . https://dx.doi.org/10.2174/1574885510999150505171712
DOI https://dx.doi.org/10.2174/1574885510999150505171712 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Genetics of Polycystic Ovary Syndrome: An Update
Current Molecular Medicine Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and <i>in vitro</i> Studies
Current Cancer Drug Targets Brain Permeable Nanoparticles
Recent Patents on CNS Drug Discovery (Discontinued) Potential for Novel Therapeutic Uses of Alpha Lipoic Acid
Current Medicinal Chemistry Low Doses of G-CSF Prevent Cerebral Infarction and Maintain Muscle Strength in an Experimental Model of Global Ischemic Stroke
Current Pharmaceutical Biotechnology Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections
Infectious Disorders - Drug Targets Development and Evaluation of Bioresponsive Tablets of a Selective COX-2 Inhibitor for Colonic Delivery
Drug Delivery Letters Iron Involvement in Multiple Signaling Pathways of Atherosclerosis: A Revisited Hypothesis
Current Medicinal Chemistry Copaiba Oil Decreases Oxidative Stress and Inflammation But not Colon Damage in Rats with TNBS-Induced Colitis
Endocrine, Metabolic & Immune Disorders - Drug Targets The Vpu Protein and its Role in HIV-1 Pathogenesis
Current Genomics Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract
Current Pharmaceutical Design Chemotherapy for Prostate Cancer
Current Pharmaceutical Design The Use of L-Glucose in Cancer Diagnosis: Results from In Vitro and In Vivo Studies
Current Medicinal Chemistry Preface [Hot Topic: Cytochrome P450 and Diseases: Implications in Drug Metabolism and Pathophysiology (Guest Editor: Vincent Pichette)]
Current Drug Metabolism Anti-Diabetic and Angio-Protective Effect of Guluronic Acid (G2013) as a New Nonsteroidal Anti-Inflammatory Drug in the Experimental Model of Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Safety of Dipeptidyl Peptidase 4 Inhibitors for Treatment of Type 2 Diabetes
Current Drug Safety Oral Antiplatelet Agents and Bleeding Risk in Relation to Major Cardiovascular Surgery
Current Drug Safety Role of C1858T Polymorphism of Lymphoid Tyrosine Phosphatase in Egyptian Children and Adolescents with Type 1 Diabetes
Current Diabetes Reviews Treatment Strategies Against Psoriasis: Principle, Perspectives and Practices
Current Drug Delivery